Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Диагностика и медикаментозная терапия эндометриоза на амбулаторном этапе
Солопова А.Е., Алиева П.М., Думановская М.Р., Табеева Г.И., Иванникова Ю.А., Сметник А.А., Павлович С.В. Диагностика и медикаментозная терапия эндометриоза на амбулаторном этапе. Гинекология. 2024;26(2):135–140. DOI: 10.26442/20795696.2024.2.202733
© ООО «КОНСИЛИУМ МЕДИКУМ», 2024 г.
© ООО «КОНСИЛИУМ МЕДИКУМ», 2024 г.
________________________________________________
Solopova AE, Alieva PM, Dumanovskaya MR, Tabeeva GI, Ivannikova IuA, Smetnik AA, Pavlovich SV. Outpatient diagnosis and drug therapy of endometriosis: A review. Gynecology. 2024;26(2):135–140.
DOI: 10.26442/20795696.2024.2.202733
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Эндометриоз поражает около 10% женщин репродуктивного возраста и может оказывать негативное влияние на качество жизни (КЖ). В связи с гетерогенностью симптомов, вплоть до отсутствия клинических проявлений, постановка диагноза на ранних стадиях затруднена. По данной причине возникает необходимость комплексно оценивать жалобы пациентки, включая тщательный сбор соматического анамнеза, результаты методов лучевой диагностики в сочетании с факторами риска развития эндометриоза. При ранней постановке диагноза предоставляется возможность досрочно начать лечение, что позволит, вероятно, избежать оперативного вмешательства. В статье представлены данные о ведении пациенток с эндометриозом в амбулаторных условиях, описаны методы неинвазивной визуальной диагностики эндометриоза. Рассмотрены современные варианты фармакотерапии, направленные на контроль развития заболевания и на улучшение КЖ пациенток в долгосрочной перспективе. Своевременно начатое медикаментозное лечение благоприятно влияет на КЖ больных, в ряде случаев приводит к регрессу объемных образований и улучшает прогноз для реализации репродуктивной функции. Трансформация фокуса на клинической диагностике в сочетании с неинвазивной визуализацией сокращает время между первой консультацией и окончательным диагнозом. Согласно современной позиции российских и международных обществ терапия должна быть длительной, соответственно, возникает необходимость в подборе лечения с возможностью предикции ответа и контроля за течением заболевания.
Ключевые слова: эндометриоз, прогестагены, консервативная терапия, магнитно-резонансная терапия, ультразвуковое исследование
Ключевые слова: эндометриоз, прогестагены, консервативная терапия, магнитно-резонансная терапия, ультразвуковое исследование
________________________________________________
Endometriosis affects about 10% of women of reproductive age and can negatively impact their quality of life (QoL). Due to the heterogeneity of symptoms or even their absence, early diagnosis is difficult. Therefore, it is necessary to comprehensively assess the patient's complaints, including a thorough review of medical history, the results of imaging studies, and risk factors for endometriosis. Early diagnosis enables preemptive treatment and avoids surgical intervention. The article presents data on managing patients with endometriosis in outpatient settings, describing methods for non-invasive imaging diagnosis of endometriosis. Current options of pharmacotherapy aimed at controlling the development of the disease and improving the QoL of patients in the long term are addressed. Timely initiated drug treatment improves the QoL of patients, in some cases, leads to a regression of the lesions, and improves the prognosis for the reproductive function. A shift in focus to clinical diagnosis, combined with non-invasive imaging, shortens the time between the first consultation and the final diagnosis. According to the current view of Russian and international professional societies, therapy should be long-term; therefore, selecting treatment with predictable responses and monitoring the course of the disease is necessary.
Keywords: endometriosis, progestogens, non-surgical therapy, magnetic resonance therapy, ultrasound examination
Полный текст
Список литературы
1. Wang Y, Nicholes K, Shih IM. The Origin and Pathogenesis of Endometriosis. Annu Rev Pathol. 2020;15:71-95. DOI:10.1146/annurev-pathmechdis-012419-032654
2. Ahn SH, Monsanto SP, Miller C, et al. Pathophysiology and Immune Dysfunction in Endometriosis. Biomed Res Int. 2015;2015:795976. DOI:10.1155/2015/795976
3. Symons LK, Miller JE, Kay VR, et al. The Immunopathophysiology of Endometriosis. Trends Mol Med. 2018;24(9):748-62. DOI:10.1016/j.molmed.2018.07.004
4. Азнаурова Я.Б., Петров И.А., Сунцова М.В., и др. Взаимосвязь экспрессии генов и степени активации сигнальных путей в эутопическом и эктопическом эндометрии пациенток с наружным генитальным эндометриозом. Проблемы репродукции. 2018;24(4):13-21 [Aznaurova YaB, Petrov IA, Suntsova MV, et al. Interconnection between gene expression and signaling pathways activation profiles in eutopic and ectopic endometrium of patients with external genital endometriosis. Russian Journal of Human Reproduction. 2018;24(4):13-21 (in Russian)]. DOI:10.17116/repro20182404113
5. Rush G, Misajon R. Examining subjective wellbeing and health-related quality of life in women with endometriosis. Health Care Women Int. 2018;39(3):303-21. DOI:10.1080/07399332.2017.1397671
6. Subedi SS, Bhansakarya R, Shrestha P, Sharma SK. Outcome of Laparoscopy in Infertile Couples attending a Teaching Hospital in Eastern Nepal: A Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc. 2020;58(231):889-92. DOI:10.31729/jnma.5542
7. Nnoaham KE, Hummelshoj L, Webster P, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril.
2011;96(2):366-73.e8. DOI:10.1016/j.fertnstert.2011.05.090
8. Martire FG, Russo C, Selntigia A, et al. Early noninvasive diagnosis of endometriosis: dysmenorrhea and specific ultrasound findings are important indicators in young women. Fertil Steril. 2023;119(3):455-64. DOI:10.1016/j.fertnstert.2022.12.004
9. Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. DOI:10.1093/hropen/hoac009
10. Avila I, Filogônio ID, Costa LM, Carneiro MM. Anatomical distribution of deep infiltrating endometriosis and its relationship to pelvic pain. J Gynecol Surg. 2016;32:99-103. DOI:10.1089/gyn.2015.0092
11. Dai Y, Leng JH, Lang JH, et al. Anatomical distribution of pelvic deep infiltrating endometriosis and its relationship with pain symptoms. Chin Med J (Engl). 2012;125(2):209-13.
12. Green IC, Burnett T, Famuyide A. Persistent Pelvic Pain in Patients With Endometriosis. Clin Obstet Gynecol. 2022;65(4):775-85. DOI:10.1097/GRF.0000000000000712
13. Signorile PG, Cassano M, Viceconte R, et al. Endometriosis: A Retrospective Analysis of Clinical Data from a Cohort of 4,083 Patients, With Focus on Symptoms. In Vivo. 2022;36(2):874-83. DOI:10.21873/invivo.12776
14. Evans SF, Brooks TA, Esterman AJ, et al. The comorbidities of dysmenorrhea: a clinical survey comparing symptom profile in women with and without endometriosis. J Pain Res. 2018;11:3181-94. DOI:10.2147/JPR.S179409
15. Fauconnier A, Staraci S, Huchon C, et al. Comparison of patient- and physician-based descriptions of symptoms of endometriosis: a qualitative study. Hum Reprod. 2013;28(10):2686-94. DOI:10.1093/humrep/det310
16. Bontempo AC, Mikesell L. Patient perceptions of misdiagnosis of endometriosis: results from an online national survey. Diagnosis (Berl). 2020;7(2):97-106.
DOI:10.1515/dx-2019-0020
17. Chapron C, Lang JH, Leng JH, et al. Factors and Regional Differences Associated with Endometriosis: A Multi-Country, Case-Control Study. Adv Ther. 2016;33(8):1385-407. DOI:10.1007/s12325-016-0366-x
18. Ballard KD, Seaman HE, de Vries CS, Wright JT. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study – Part 1. BJOG. 2008;115(11):1382-91. DOI:10.1111/j.1471-0528.2008.01878.x
19. Novellas S, Chassang M, Bouaziz J, et al. Anterior pelvic endometriosis: MRI features. Abdom Imaging. 2010;35(6):742-9. DOI:10.1007/s00261-010-9600-1
20. Saha R, Pettersson HJ, Svedberg P, et al. Heritability of endometriosis. Fertil Steril. 2015;104(4):947-52. DOI:10.1016/j.fertnstert.2015.06.035
21. Allaire C, Bedaiwy MA, Yong PJ. Diagnostic et gestion thérapeutique de l’endométriose. CMAJ. 2023;195(24):E853-62. DOI:10.1503/cmaj.220637-f
22. Riazi H, Tehranian N, Ziaei S, et al. Clinical diagnosis of pelvic endometriosis: a scoping review. BMC Womens Health. 2015;15:39. DOI:10.1186/s12905-015-0196-z
23. Эндометриоз: клинические рекомендации Минздрава России. 2020. Режим доступа: https://cr.minzdrav.gov.ru/recomend/259_1. Ссылка активна на 05.09.2023 [Endometrioz: klinicheskie rekomendatsii Minzdrava Rossii. 2020. Available at: https://cr.minzdrav.gov.ru/recomend/259_1. Accessed: 05.09.2023 (in Russian)].
24. Tomassetti C, Johnson NP, Petrozza J, et al. An international terminology for endometriosis. Facts Views Vis Obgyn. 2021;13(4):295-304. DOI:10.52054/FVVO.13.4.036
25. Johnson NP, Hummelshoj L, Adamson GD, et al. World Endometriosis Society consensus on the classification of endometriosis. Hum Reprod. 2017;32(2):315-24. DOI:10.1093/humrep/dew293
26. Vigueras Smith A, Cabrera R, Trippia C, et al. Indirect and atypical imaging signals of endometriosis: A wide range of manifestations. Facts Views Vis Obgyn. 2021;13(4):339-56. DOI:10.52054/FVVO.13.4.048
27. Sud S, Buxi TBS, Sheth S, Ghuman SS. Endometriosis and Its Myriad Presentations: Magnetic Resonance Imaging-Based Pictorial Review. Indian J Radiol Imaging.
2021;31(1):193-202. DOI:10.1055/s-0041-1729670
28. Baușic A, Coroleucă C, Coroleucă C, et al. Transvaginal Ultrasound vs Magnetic Resonance Imaging (MRI) Value in Endometriosis Diagnosis. Diagnostics (Basel). 2022;12(7):1767. DOI:10.3390/diagnostics12071767
29. Bazot M, Thomassin I, Hourani R, et al. Diagnostic accuracy of transvaginal sonography for deep pelvic endometriosis. Ultrasound Obstet Gynecol. 2004;24(2):180-5. DOI:10.1002/uog.1108
30. Guerriero S, Condous G, van den Bosch T, et al. Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group. Ultrasound Obstet Gynecol. 2016;48(3):318-32. DOI:10.1002/uog.15955
31. Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019;15(11):666-82.
DOI:10.1038/s41574-019-0245-z
32. Bazot M, Bharwani N, Huchon C, et al. European society of urogenital radiology (ESUR) guidelines: MR imaging of pelvic endometriosis. Eur Radiol. 2017;27(7):2765-75. DOI:10.1007/s00330-016-4673-z
33. Borghese G, Coppola F, Raimondo D, et al. 3D Patient-Specific Virtual Models for Presurgical Planning in Patients with Recto-Sigmoid Endometriosis Nodules: A Pilot Study. Medicina (Kaunas). 2022;58(1). DOI:10.3390/medicina58010086
34. Uncu G, Kasapoglu I, Ozerkan K, et al. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Hum Reprod. 2013;28(8):2140-5. DOI:10.1093/humrep/det123
35. Vannuccini S, Clemenza S, Rossi M, Petraglia F. Hormonal treatments for endometriosis: The endocrine background. Rev Endocr Metab Disord. 2022;23(3):333-55. DOI:10.1007/s11154-021-09666-w
36. Casper RF. Introduction: A focus on the medical management of endometriosis. Fertil Steril. 2017;107(3):521-2. DOI:10.1016/j.fertnstert.2017.01.008
37. Mitchell JB, Chetty S, Kathrada F. Progestins in the symptomatic management of endometriosis: a meta-analysis on their effectiveness and safety. BMC Womens Health. 2022;22(1):526. DOI:10.1186/s12905-022-02122-0
38. Matsuura M, Tamate M, Tabuchi Y, et al. Prediction of the therapeutic effect of dienogest in ovarian endometrial cysts using the apparent diffusion coefficient. Gynecol Endocrinol. 2014;30(8):597-9. DOI:10.3109/09513590.2014.911277
39. Uludag SZ, Demirtas E, Sahin Y, Aygen EM. Dienogest reduces endometrioma volume and endometriosis-related pain symptoms. J Obstet Gynaecol. 2021;41(8):1246-51. DOI:10.1080/01443615.2020.1867962
40. Saglik Gokmen B, Topbas Selcuki NF, Aydın A, et al. Effects of Dienogest Therapy on Endometriosis-Related Dysmenorrhea, Dyspareunia, and Endometrioma Size. Cureus. 2023;15(1):e34162. DOI:10.7759/cureus.34162
41. Kizilkaya Y, Ibanoglu MC, Kıykac Altinbas S, Engin-Ustun Y. A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms. Gynecol Endocrinol. 2022;38(5):403-6. DOI:10.1080/09513590.2022.2053956
42. Muzii L, Galati G, Di Tucci C, et al. Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain. Gynecol Endocrinol. 2020;36(1):81-3. DOI:10.1080/09513590.2019.1640199
43. Leonardo-Pinto JP, Benetti-Pinto CL, Cursino K, Yela DA. Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission. Eur J Obstet Gynecol Reprod Biol. 2017;211:108-11. DOI:10.1016/j.ejogrb.2017.02.015
44. Chen LH, Lo WC, Huang HY, Wu HM. A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment. Int J Mol Sci. 2023;24(8). DOI:10.3390/ijms24087503
45. Nirgianakis K, Vaineau C, Agliati L, et al. Risk factors for non-response and discontinuation of Dienogest in endometriosis patients: A cohort study. Acta Obstet Gynecol Scand. 2021;100(1):30-40. DOI:10.1111/aogs.13969
46. Griesinger G, Tournaye H, Macklon N, et al. Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction. Reprod Biomed Online. 2019;38(2):249-59. DOI:10.1016/j.rbmo.2018.11.017
47. Сухих Г.Т., Серов В.Н., Адамян Л.В., и др. Алгоритмы ведения пациенток с эндометриозом: согласованная позиция экспертов Российского общества акушеров-гинекологов. Акушерство и гинекология. 2023;5:159-76 [Sukhikh GT, Serov VN, Adamyan LV, et al. Algorithms for the management of patients with endometriosis: the agreed position of experts of the Russian Society of Obstetricians and Gynecologists. Obstetrics and Gynecology. 2023;5:159-76 (in Russian)]. DOI:10.18565/aig.2023.132
48. Kitawaki J, Koga K, Kanzo T, Momoeda M. An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open-label multicenter clinical study. Reprod Med Biol. 2021;20(3):345-51. DOI:10.1002/rmb2.12391
49. Taniguchi F, Ota I, Iba Y, et al. The efficacy and safety of dydrogesterone for treatment of dysmenorrhea: An open-label multicenter clinical study. J Obstet Gynaecol Res. 2019;45(1):168-75. DOI:10.1111/jog.13807
50. Сухих Г.Т., Адамян Л.В., Дубровина С.О., и др. Длительные циклические и непрерывные режимы приема дидрогестерона эффективны для уменьшения хронической тазовой боли у женщин с эндометриозом: результаты исследования ORCHIDEA. Fertil Steril. 2021;116(06):1568-77 [Sukhikh GT, Adamyan LV, Dubrovina SO, et al. Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study. Fertil Steril. 2021;116(06):1568-77 (in Russian)]. DOI:10.1016/j.fertnstert.2021.07.1194
51. Triantafyllidou O, Kolovos G, Voros C, et al. Time to full effect, following treatment with combined oral contraceptives (cyclic versus continuous administration) in patients with endometriosis after laparoscopic surgery: a prospective cohort study. Hum Fertil (Camb). 2022;25(1):72-9. DOI:10.1080/14647273.2019.1704451
52. Harada T, Momoeda M, Taketani Y, et al. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2008;90(5):1583-8. DOI:10.1016/j.fertnstert.2007.08.051
53. Seracchioli R, Mabrouk M, Frascà C, et al. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertil Steril. 2010;94(2):464-71. DOI:10.1016/j.fertnstert.2009.03.083
54. Takamura M, Koga K, Osuga Y, et al. Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision. Hum Reprod. 2009;24(12):3042-8. DOI:10.1093/humrep/dep297
55. Harada T, Kosaka S, Elliesen J, et al. Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial. Fertil Steril. 2017;108(5):798-805. DOI:10.1016/j.fertnstert.2017.07.1165
56. Angioni S, Pontis A, Malune ME, et al. Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol. 2020;36(1):84-6. DOI:10.1080/09513590.2019.1640674
57. Becker CM, Gattrell WT, Gude K, Singh SS. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil Steril. 2017;108(1):125-36. DOI:10.1016/j.fertnstert.2017.05.004
58. Tsujioka H, Inoue Y, Emoto M, et al. The efficacy of preoperative hormonal therapy before laparoscopic cystectomy of ovarian endometriomas. J Obstet Gynaecol Res. 2009;35(4):782-6. DOI:10.1111/j.1447-0756.2009.01017.x
59. Cantor A, Tannus S, Son WY, et al. A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF. Reprod Biomed Online. 2019;38(4):520-7. DOI:10.1016/j.rbmo.2018.12.028
60. Surrey ES. GnRH agonists in the treatment of symptomatic endometriosis: a review. F S Rep. 2023;4(Suppl. 2):40-5. DOI:10.1016/j.xfre.2022.11.009
61. Ceccaroni M, Clarizia R, Liverani S, et al. Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial. Gynecol Endocrinol. 2021;37(10):930-3. DOI:10.1080/09513590.2021.1929151
2. Ahn SH, Monsanto SP, Miller C, et al. Pathophysiology and Immune Dysfunction in Endometriosis. Biomed Res Int. 2015;2015:795976. DOI:10.1155/2015/795976
3. Symons LK, Miller JE, Kay VR, et al. The Immunopathophysiology of Endometriosis. Trends Mol Med. 2018;24(9):748-62. DOI:10.1016/j.molmed.2018.07.004
4. Азнаурова Я.Б., Петров И.А., Сунцова М.В., и др. Взаимосвязь экспрессии генов и степени активации сигнальных путей в эутопическом и эктопическом эндометрии пациенток с наружным генитальным эндометриозом. Проблемы репродукции. 2018;24(4):13-21 [Aznaurova YaB, Petrov IA, Suntsova MV, et al. Interconnection between gene expression and signaling pathways activation profiles in eutopic and ectopic endometrium of patients with external genital endometriosis. Russian Journal of Human Reproduction. 2018;24(4):13-21 (in Russian)]. DOI:10.17116/repro20182404113
5. Rush G, Misajon R. Examining subjective wellbeing and health-related quality of life in women with endometriosis. Health Care Women Int. 2018;39(3):303-21. DOI:10.1080/07399332.2017.1397671
6. Subedi SS, Bhansakarya R, Shrestha P, Sharma SK. Outcome of Laparoscopy in Infertile Couples attending a Teaching Hospital in Eastern Nepal: A Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc. 2020;58(231):889-92. DOI:10.31729/jnma.5542
7. Nnoaham KE, Hummelshoj L, Webster P, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril.
2011;96(2):366-73.e8. DOI:10.1016/j.fertnstert.2011.05.090
8. Martire FG, Russo C, Selntigia A, et al. Early noninvasive diagnosis of endometriosis: dysmenorrhea and specific ultrasound findings are important indicators in young women. Fertil Steril. 2023;119(3):455-64. DOI:10.1016/j.fertnstert.2022.12.004
9. Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. DOI:10.1093/hropen/hoac009
10. Avila I, Filogônio ID, Costa LM, Carneiro MM. Anatomical distribution of deep infiltrating endometriosis and its relationship to pelvic pain. J Gynecol Surg. 2016;32:99-103. DOI:10.1089/gyn.2015.0092
11. Dai Y, Leng JH, Lang JH, et al. Anatomical distribution of pelvic deep infiltrating endometriosis and its relationship with pain symptoms. Chin Med J (Engl). 2012;125(2):209-13.
12. Green IC, Burnett T, Famuyide A. Persistent Pelvic Pain in Patients With Endometriosis. Clin Obstet Gynecol. 2022;65(4):775-85. DOI:10.1097/GRF.0000000000000712
13. Signorile PG, Cassano M, Viceconte R, et al. Endometriosis: A Retrospective Analysis of Clinical Data from a Cohort of 4,083 Patients, With Focus on Symptoms. In Vivo. 2022;36(2):874-83. DOI:10.21873/invivo.12776
14. Evans SF, Brooks TA, Esterman AJ, et al. The comorbidities of dysmenorrhea: a clinical survey comparing symptom profile in women with and without endometriosis. J Pain Res. 2018;11:3181-94. DOI:10.2147/JPR.S179409
15. Fauconnier A, Staraci S, Huchon C, et al. Comparison of patient- and physician-based descriptions of symptoms of endometriosis: a qualitative study. Hum Reprod. 2013;28(10):2686-94. DOI:10.1093/humrep/det310
16. Bontempo AC, Mikesell L. Patient perceptions of misdiagnosis of endometriosis: results from an online national survey. Diagnosis (Berl). 2020;7(2):97-106.
DOI:10.1515/dx-2019-0020
17. Chapron C, Lang JH, Leng JH, et al. Factors and Regional Differences Associated with Endometriosis: A Multi-Country, Case-Control Study. Adv Ther. 2016;33(8):1385-407. DOI:10.1007/s12325-016-0366-x
18. Ballard KD, Seaman HE, de Vries CS, Wright JT. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study – Part 1. BJOG. 2008;115(11):1382-91. DOI:10.1111/j.1471-0528.2008.01878.x
19. Novellas S, Chassang M, Bouaziz J, et al. Anterior pelvic endometriosis: MRI features. Abdom Imaging. 2010;35(6):742-9. DOI:10.1007/s00261-010-9600-1
20. Saha R, Pettersson HJ, Svedberg P, et al. Heritability of endometriosis. Fertil Steril. 2015;104(4):947-52. DOI:10.1016/j.fertnstert.2015.06.035
21. Allaire C, Bedaiwy MA, Yong PJ. Diagnostic et gestion thérapeutique de l’endométriose. CMAJ. 2023;195(24):E853-62. DOI:10.1503/cmaj.220637-f
22. Riazi H, Tehranian N, Ziaei S, et al. Clinical diagnosis of pelvic endometriosis: a scoping review. BMC Womens Health. 2015;15:39. DOI:10.1186/s12905-015-0196-z
23. Эндометриоз: клинические рекомендации Минздрава России. 2020. Режим доступа: https://cr.minzdrav.gov.ru/recomend/259_1. Ссылка активна на 05.09.2023 [Endometrioz: klinicheskie rekomendatsii Minzdrava Rossii. 2020. Available at: https://cr.minzdrav.gov.ru/recomend/259_1. Accessed: 05.09.2023 (in Russian)].
24. Tomassetti C, Johnson NP, Petrozza J, et al. An international terminology for endometriosis. Facts Views Vis Obgyn. 2021;13(4):295-304. DOI:10.52054/FVVO.13.4.036
25. Johnson NP, Hummelshoj L, Adamson GD, et al. World Endometriosis Society consensus on the classification of endometriosis. Hum Reprod. 2017;32(2):315-24. DOI:10.1093/humrep/dew293
26. Vigueras Smith A, Cabrera R, Trippia C, et al. Indirect and atypical imaging signals of endometriosis: A wide range of manifestations. Facts Views Vis Obgyn. 2021;13(4):339-56. DOI:10.52054/FVVO.13.4.048
27. Sud S, Buxi TBS, Sheth S, Ghuman SS. Endometriosis and Its Myriad Presentations: Magnetic Resonance Imaging-Based Pictorial Review. Indian J Radiol Imaging.
2021;31(1):193-202. DOI:10.1055/s-0041-1729670
28. Baușic A, Coroleucă C, Coroleucă C, et al. Transvaginal Ultrasound vs Magnetic Resonance Imaging (MRI) Value in Endometriosis Diagnosis. Diagnostics (Basel). 2022;12(7):1767. DOI:10.3390/diagnostics12071767
29. Bazot M, Thomassin I, Hourani R, et al. Diagnostic accuracy of transvaginal sonography for deep pelvic endometriosis. Ultrasound Obstet Gynecol. 2004;24(2):180-5. DOI:10.1002/uog.1108
30. Guerriero S, Condous G, van den Bosch T, et al. Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group. Ultrasound Obstet Gynecol. 2016;48(3):318-32. DOI:10.1002/uog.15955
31. Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019;15(11):666-82.
DOI:10.1038/s41574-019-0245-z
32. Bazot M, Bharwani N, Huchon C, et al. European society of urogenital radiology (ESUR) guidelines: MR imaging of pelvic endometriosis. Eur Radiol. 2017;27(7):2765-75. DOI:10.1007/s00330-016-4673-z
33. Borghese G, Coppola F, Raimondo D, et al. 3D Patient-Specific Virtual Models for Presurgical Planning in Patients with Recto-Sigmoid Endometriosis Nodules: A Pilot Study. Medicina (Kaunas). 2022;58(1). DOI:10.3390/medicina58010086
34. Uncu G, Kasapoglu I, Ozerkan K, et al. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Hum Reprod. 2013;28(8):2140-5. DOI:10.1093/humrep/det123
35. Vannuccini S, Clemenza S, Rossi M, Petraglia F. Hormonal treatments for endometriosis: The endocrine background. Rev Endocr Metab Disord. 2022;23(3):333-55. DOI:10.1007/s11154-021-09666-w
36. Casper RF. Introduction: A focus on the medical management of endometriosis. Fertil Steril. 2017;107(3):521-2. DOI:10.1016/j.fertnstert.2017.01.008
37. Mitchell JB, Chetty S, Kathrada F. Progestins in the symptomatic management of endometriosis: a meta-analysis on their effectiveness and safety. BMC Womens Health. 2022;22(1):526. DOI:10.1186/s12905-022-02122-0
38. Matsuura M, Tamate M, Tabuchi Y, et al. Prediction of the therapeutic effect of dienogest in ovarian endometrial cysts using the apparent diffusion coefficient. Gynecol Endocrinol. 2014;30(8):597-9. DOI:10.3109/09513590.2014.911277
39. Uludag SZ, Demirtas E, Sahin Y, Aygen EM. Dienogest reduces endometrioma volume and endometriosis-related pain symptoms. J Obstet Gynaecol. 2021;41(8):1246-51. DOI:10.1080/01443615.2020.1867962
40. Saglik Gokmen B, Topbas Selcuki NF, Aydın A, et al. Effects of Dienogest Therapy on Endometriosis-Related Dysmenorrhea, Dyspareunia, and Endometrioma Size. Cureus. 2023;15(1):e34162. DOI:10.7759/cureus.34162
41. Kizilkaya Y, Ibanoglu MC, Kıykac Altinbas S, Engin-Ustun Y. A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms. Gynecol Endocrinol. 2022;38(5):403-6. DOI:10.1080/09513590.2022.2053956
42. Muzii L, Galati G, Di Tucci C, et al. Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain. Gynecol Endocrinol. 2020;36(1):81-3. DOI:10.1080/09513590.2019.1640199
43. Leonardo-Pinto JP, Benetti-Pinto CL, Cursino K, Yela DA. Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission. Eur J Obstet Gynecol Reprod Biol. 2017;211:108-11. DOI:10.1016/j.ejogrb.2017.02.015
44. Chen LH, Lo WC, Huang HY, Wu HM. A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment. Int J Mol Sci. 2023;24(8). DOI:10.3390/ijms24087503
45. Nirgianakis K, Vaineau C, Agliati L, et al. Risk factors for non-response and discontinuation of Dienogest in endometriosis patients: A cohort study. Acta Obstet Gynecol Scand. 2021;100(1):30-40. DOI:10.1111/aogs.13969
46. Griesinger G, Tournaye H, Macklon N, et al. Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction. Reprod Biomed Online. 2019;38(2):249-59. DOI:10.1016/j.rbmo.2018.11.017
47. Сухих Г.Т., Серов В.Н., Адамян Л.В., и др. Алгоритмы ведения пациенток с эндометриозом: согласованная позиция экспертов Российского общества акушеров-гинекологов. Акушерство и гинекология. 2023;5:159-76 [Sukhikh GT, Serov VN, Adamyan LV, et al. Algorithms for the management of patients with endometriosis: the agreed position of experts of the Russian Society of Obstetricians and Gynecologists. Obstetrics and Gynecology. 2023;5:159-76 (in Russian)]. DOI:10.18565/aig.2023.132
48. Kitawaki J, Koga K, Kanzo T, Momoeda M. An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open-label multicenter clinical study. Reprod Med Biol. 2021;20(3):345-51. DOI:10.1002/rmb2.12391
49. Taniguchi F, Ota I, Iba Y, et al. The efficacy and safety of dydrogesterone for treatment of dysmenorrhea: An open-label multicenter clinical study. J Obstet Gynaecol Res. 2019;45(1):168-75. DOI:10.1111/jog.13807
50. Сухих Г.Т., Адамян Л.В., Дубровина С.О., и др. Длительные циклические и непрерывные режимы приема дидрогестерона эффективны для уменьшения хронической тазовой боли у женщин с эндометриозом: результаты исследования ORCHIDEA. Fertil Steril. 2021;116(06):1568-77 [Sukhikh GT, Adamyan LV, Dubrovina SO, et al. Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study. Fertil Steril. 2021;116(06):1568-77 (in Russian)]. DOI:10.1016/j.fertnstert.2021.07.1194
51. Triantafyllidou O, Kolovos G, Voros C, et al. Time to full effect, following treatment with combined oral contraceptives (cyclic versus continuous administration) in patients with endometriosis after laparoscopic surgery: a prospective cohort study. Hum Fertil (Camb). 2022;25(1):72-9. DOI:10.1080/14647273.2019.1704451
52. Harada T, Momoeda M, Taketani Y, et al. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2008;90(5):1583-8. DOI:10.1016/j.fertnstert.2007.08.051
53. Seracchioli R, Mabrouk M, Frascà C, et al. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertil Steril. 2010;94(2):464-71. DOI:10.1016/j.fertnstert.2009.03.083
54. Takamura M, Koga K, Osuga Y, et al. Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision. Hum Reprod. 2009;24(12):3042-8. DOI:10.1093/humrep/dep297
55. Harada T, Kosaka S, Elliesen J, et al. Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial. Fertil Steril. 2017;108(5):798-805. DOI:10.1016/j.fertnstert.2017.07.1165
56. Angioni S, Pontis A, Malune ME, et al. Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol. 2020;36(1):84-6. DOI:10.1080/09513590.2019.1640674
57. Becker CM, Gattrell WT, Gude K, Singh SS. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil Steril. 2017;108(1):125-36. DOI:10.1016/j.fertnstert.2017.05.004
58. Tsujioka H, Inoue Y, Emoto M, et al. The efficacy of preoperative hormonal therapy before laparoscopic cystectomy of ovarian endometriomas. J Obstet Gynaecol Res. 2009;35(4):782-6. DOI:10.1111/j.1447-0756.2009.01017.x
59. Cantor A, Tannus S, Son WY, et al. A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF. Reprod Biomed Online. 2019;38(4):520-7. DOI:10.1016/j.rbmo.2018.12.028
60. Surrey ES. GnRH agonists in the treatment of symptomatic endometriosis: a review. F S Rep. 2023;4(Suppl. 2):40-5. DOI:10.1016/j.xfre.2022.11.009
61. Ceccaroni M, Clarizia R, Liverani S, et al. Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial. Gynecol Endocrinol. 2021;37(10):930-3. DOI:10.1080/09513590.2021.1929151
________________________________________________
1. Wang Y, Nicholes K, Shih IM. The Origin and Pathogenesis of Endometriosis. Annu Rev Pathol. 2020;15:71-95. DOI:10.1146/annurev-pathmechdis-012419-032654
2. Ahn SH, Monsanto SP, Miller C, et al. Pathophysiology and Immune Dysfunction in Endometriosis. Biomed Res Int. 2015;2015:795976. DOI:10.1155/2015/795976
3. Symons LK, Miller JE, Kay VR, et al. The Immunopathophysiology of Endometriosis. Trends Mol Med. 2018;24(9):748-62. DOI:10.1016/j.molmed.2018.07.004
4. Aznaurova YaB, Petrov IA, Suntsova MV, et al. Interconnection between gene expression and signaling pathways activation profiles in eutopic and ectopic endometrium of patients with external genital endometriosis. Russian Journal of Human Reproduction. 2018;24(4):13-21 (in Russian). DOI:10.17116/repro20182404113
5. Rush G, Misajon R. Examining subjective wellbeing and health-related quality of life in women with endometriosis. Health Care Women Int. 2018;39(3):303-21. DOI:10.1080/07399332.2017.1397671
6. Subedi SS, Bhansakarya R, Shrestha P, Sharma SK. Outcome of Laparoscopy in Infertile Couples attending a Teaching Hospital in Eastern Nepal: A Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc. 2020;58(231):889-92. DOI:10.31729/jnma.5542
7. Nnoaham KE, Hummelshoj L, Webster P, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril.
2011;96(2):366-73.e8. DOI:10.1016/j.fertnstert.2011.05.090
8. Martire FG, Russo C, Selntigia A, et al. Early noninvasive diagnosis of endometriosis: dysmenorrhea and specific ultrasound findings are important indicators in young women. Fertil Steril. 2023;119(3):455-64. DOI:10.1016/j.fertnstert.2022.12.004
9. Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. DOI:10.1093/hropen/hoac009
10. Avila I, Filogônio ID, Costa LM, Carneiro MM. Anatomical distribution of deep infiltrating endometriosis and its relationship to pelvic pain. J Gynecol Surg. 2016;32:99-103. DOI:10.1089/gyn.2015.0092
11. Dai Y, Leng JH, Lang JH, et al. Anatomical distribution of pelvic deep infiltrating endometriosis and its relationship with pain symptoms. Chin Med J (Engl). 2012;125(2):209-13.
12. Green IC, Burnett T, Famuyide A. Persistent Pelvic Pain in Patients With Endometriosis. Clin Obstet Gynecol. 2022;65(4):775-85. DOI:10.1097/GRF.0000000000000712
13. Signorile PG, Cassano M, Viceconte R, et al. Endometriosis: A Retrospective Analysis of Clinical Data from a Cohort of 4,083 Patients, With Focus on Symptoms. In Vivo. 2022;36(2):874-83. DOI:10.21873/invivo.12776
14. Evans SF, Brooks TA, Esterman AJ, et al. The comorbidities of dysmenorrhea: a clinical survey comparing symptom profile in women with and without endometriosis. J Pain Res. 2018;11:3181-94. DOI:10.2147/JPR.S179409
15. Fauconnier A, Staraci S, Huchon C, et al. Comparison of patient- and physician-based descriptions of symptoms of endometriosis: a qualitative study. Hum Reprod. 2013;28(10):2686-94. DOI:10.1093/humrep/det310
16. Bontempo AC, Mikesell L. Patient perceptions of misdiagnosis of endometriosis: results from an online national survey. Diagnosis (Berl). 2020;7(2):97-106.
DOI:10.1515/dx-2019-0020
17. Chapron C, Lang JH, Leng JH, et al. Factors and Regional Differences Associated with Endometriosis: A Multi-Country, Case-Control Study. Adv Ther. 2016;33(8):1385-407. DOI:10.1007/s12325-016-0366-x
18. Ballard KD, Seaman HE, de Vries CS, Wright JT. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study – Part 1. BJOG. 2008;115(11):1382-91. DOI:10.1111/j.1471-0528.2008.01878.x
19. Novellas S, Chassang M, Bouaziz J, et al. Anterior pelvic endometriosis: MRI features. Abdom Imaging. 2010;35(6):742-9. DOI:10.1007/s00261-010-9600-1
20. Saha R, Pettersson HJ, Svedberg P, et al. Heritability of endometriosis. Fertil Steril. 2015;104(4):947-52. DOI:10.1016/j.fertnstert.2015.06.035
21. Allaire C, Bedaiwy MA, Yong PJ. Diagnostic et gestion thérapeutique de l’endométriose. CMAJ. 2023;195(24):E853-62. DOI:10.1503/cmaj.220637-f
22. Riazi H, Tehranian N, Ziaei S, et al. Clinical diagnosis of pelvic endometriosis: a scoping review. BMC Womens Health. 2015;15:39. DOI:10.1186/s12905-015-0196-z
23. Endometrioz: klinicheskie rekomendatsii Minzdrava Rossii. 2020. Available at: https://cr.minzdrav.gov.ru/recomend/259_1. Accessed: 05.09.2023 (in Russian).
24. Tomassetti C, Johnson NP, Petrozza J, et al. An international terminology for endometriosis. Facts Views Vis Obgyn. 2021;13(4):295-304. DOI:10.52054/FVVO.13.4.036
25. Johnson NP, Hummelshoj L, Adamson GD, et al. World Endometriosis Society consensus on the classification of endometriosis. Hum Reprod. 2017;32(2):315-24. DOI:10.1093/humrep/dew293
26. Vigueras Smith A, Cabrera R, Trippia C, et al. Indirect and atypical imaging signals of endometriosis: A wide range of manifestations. Facts Views Vis Obgyn. 2021;13(4):339-56. DOI:10.52054/FVVO.13.4.048
27. Sud S, Buxi TBS, Sheth S, Ghuman SS. Endometriosis and Its Myriad Presentations: Magnetic Resonance Imaging-Based Pictorial Review. Indian J Radiol Imaging.
2021;31(1):193-202. DOI:10.1055/s-0041-1729670
28. Baușic A, Coroleucă C, Coroleucă C, et al. Transvaginal Ultrasound vs Magnetic Resonance Imaging (MRI) Value in Endometriosis Diagnosis. Diagnostics (Basel). 2022;12(7):1767. DOI:10.3390/diagnostics12071767
29. Bazot M, Thomassin I, Hourani R, et al. Diagnostic accuracy of transvaginal sonography for deep pelvic endometriosis. Ultrasound Obstet Gynecol. 2004;24(2):180-5. DOI:10.1002/uog.1108
30. Guerriero S, Condous G, van den Bosch T, et al. Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group. Ultrasound Obstet Gynecol. 2016;48(3):318-32. DOI:10.1002/uog.15955
31. Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019;15(11):666-82.
DOI:10.1038/s41574-019-0245-z
32. Bazot M, Bharwani N, Huchon C, et al. European society of urogenital radiology (ESUR) guidelines: MR imaging of pelvic endometriosis. Eur Radiol. 2017;27(7):2765-75. DOI:10.1007/s00330-016-4673-z
33. Borghese G, Coppola F, Raimondo D, et al. 3D Patient-Specific Virtual Models for Presurgical Planning in Patients with Recto-Sigmoid Endometriosis Nodules: A Pilot Study. Medicina (Kaunas). 2022;58(1). DOI:10.3390/medicina58010086
34. Uncu G, Kasapoglu I, Ozerkan K, et al. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Hum Reprod. 2013;28(8):2140-5. DOI:10.1093/humrep/det123
35. Vannuccini S, Clemenza S, Rossi M, Petraglia F. Hormonal treatments for endometriosis: The endocrine background. Rev Endocr Metab Disord. 2022;23(3):333-55. DOI:10.1007/s11154-021-09666-w
36. Casper RF. Introduction: A focus on the medical management of endometriosis. Fertil Steril. 2017;107(3):521-2. DOI:10.1016/j.fertnstert.2017.01.008
37. Mitchell JB, Chetty S, Kathrada F. Progestins in the symptomatic management of endometriosis: a meta-analysis on their effectiveness and safety. BMC Womens Health. 2022;22(1):526. DOI:10.1186/s12905-022-02122-0
38. Matsuura M, Tamate M, Tabuchi Y, et al. Prediction of the therapeutic effect of dienogest in ovarian endometrial cysts using the apparent diffusion coefficient. Gynecol Endocrinol. 2014;30(8):597-9. DOI:10.3109/09513590.2014.911277
39. Uludag SZ, Demirtas E, Sahin Y, Aygen EM. Dienogest reduces endometrioma volume and endometriosis-related pain symptoms. J Obstet Gynaecol. 2021;41(8):1246-51. DOI:10.1080/01443615.2020.1867962
40. Saglik Gokmen B, Topbas Selcuki NF, Aydın A, et al. Effects of Dienogest Therapy on Endometriosis-Related Dysmenorrhea, Dyspareunia, and Endometrioma Size. Cureus. 2023;15(1):e34162. DOI:10.7759/cureus.34162
41. Kizilkaya Y, Ibanoglu MC, Kıykac Altinbas S, Engin-Ustun Y. A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms. Gynecol Endocrinol. 2022;38(5):403-6. DOI:10.1080/09513590.2022.2053956
42. Muzii L, Galati G, Di Tucci C, et al. Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain. Gynecol Endocrinol. 2020;36(1):81-3. DOI:10.1080/09513590.2019.1640199
43. Leonardo-Pinto JP, Benetti-Pinto CL, Cursino K, Yela DA. Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission. Eur J Obstet Gynecol Reprod Biol. 2017;211:108-11. DOI:10.1016/j.ejogrb.2017.02.015
44. Chen LH, Lo WC, Huang HY, Wu HM. A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment. Int J Mol Sci. 2023;24(8). DOI:10.3390/ijms24087503
45. Nirgianakis K, Vaineau C, Agliati L, et al. Risk factors for non-response and discontinuation of Dienogest in endometriosis patients: A cohort study. Acta Obstet Gynecol Scand. 2021;100(1):30-40. DOI:10.1111/aogs.13969
46. Griesinger G, Tournaye H, Macklon N, et al. Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction. Reprod Biomed Online. 2019;38(2):249-59. DOI:10.1016/j.rbmo.2018.11.017
47. Sukhikh GT, Serov VN, Adamyan LV, et al. Algorithms for the management of patients with endometriosis: the agreed position of experts of the Russian Society of Obstetricians and Gynecologists. Obstetrics and Gynecology. 2023;5:159-76 (in Russian). DOI:10.18565/aig.2023.132
48. Kitawaki J, Koga K, Kanzo T, Momoeda M. An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open-label multicenter clinical study. Reprod Med Biol. 2021;20(3):345-51. DOI:10.1002/rmb2.12391
49. Taniguchi F, Ota I, Iba Y, et al. The efficacy and safety of dydrogesterone for treatment of dysmenorrhea: An open-label multicenter clinical study. J Obstet Gynaecol Res. 2019;45(1):168-75. DOI:10.1111/jog.13807
50. Sukhikh GT, Adamyan LV, Dubrovina SO, et al. Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study. Fertil Steril. 2021;116(06):1568-77 (in Russian). DOI:10.1016/j.fertnstert.2021.07.1194
51. Triantafyllidou O, Kolovos G, Voros C, et al. Time to full effect, following treatment with combined oral contraceptives (cyclic versus continuous administration) in patients with endometriosis after laparoscopic surgery: a prospective cohort study. Hum Fertil (Camb). 2022;25(1):72-9. DOI:10.1080/14647273.2019.1704451
52. Harada T, Momoeda M, Taketani Y, et al. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2008;90(5):1583-8. DOI:10.1016/j.fertnstert.2007.08.051
53. Seracchioli R, Mabrouk M, Frascà C, et al. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertil Steril. 2010;94(2):464-71. DOI:10.1016/j.fertnstert.2009.03.083
54. Takamura M, Koga K, Osuga Y, et al. Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision. Hum Reprod. 2009;24(12):3042-8. DOI:10.1093/humrep/dep297
55. Harada T, Kosaka S, Elliesen J, et al. Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial. Fertil Steril. 2017;108(5):798-805. DOI:10.1016/j.fertnstert.2017.07.1165
56. Angioni S, Pontis A, Malune ME, et al. Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol. 2020;36(1):84-6. DOI:10.1080/09513590.2019.1640674
57. Becker CM, Gattrell WT, Gude K, Singh SS. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil Steril. 2017;108(1):125-36. DOI:10.1016/j.fertnstert.2017.05.004
58. Tsujioka H, Inoue Y, Emoto M, et al. The efficacy of preoperative hormonal therapy before laparoscopic cystectomy of ovarian endometriomas. J Obstet Gynaecol Res. 2009;35(4):782-6. DOI:10.1111/j.1447-0756.2009.01017.x
59. Cantor A, Tannus S, Son WY, et al. A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF. Reprod Biomed Online. 2019;38(4):520-7. DOI:10.1016/j.rbmo.2018.12.028
60. Surrey ES. GnRH agonists in the treatment of symptomatic endometriosis: a review. F S Rep. 2023;4(Suppl. 2):40-5. DOI:10.1016/j.xfre.2022.11.009
61. Ceccaroni M, Clarizia R, Liverani S, et al. Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial. Gynecol Endocrinol. 2021;37(10):930-3. DOI:10.1080/09513590.2021.1929151
Авторы
А.Е. Солопова1, П.М. Алиева*1, М.Р. Думановская1, Г.И. Табеева1, Ю.А. Иванникова2, А.А. Сметник1, С.В. Павлович1,2
1ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии им. акад. В.И. Кулакова» Минздрава России, Москва, Россия;
2ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
*aalievapm@gmail.com
1ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии им. акад. В.И. Кулакова» Минздрава России, Москва, Россия;
2ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
*aalievapm@gmail.com
________________________________________________
Alina E. Solopova1, Patimat M. Alieva*1, Madina R. Dumanovskaya1, Guzal I. Tabeeva1, Iuliia A. Ivannikova2, Antonina A. Smetnik1, Stanislav V. Pavlovich1,2
1Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia;
2Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
*aalievapm@gmail.com
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.